Growth Hormone Secretion in Prader‐Willi Syndrome
- 1 November 1990
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 79 (11) , 1059-1062
- https://doi.org/10.1111/j.1651-2227.1990.tb11383.x
Abstract
Integrated 12-hour growth hormone secretion studies, peak growth hormone response to clonidine provocation. Somatomedin-C levels, T-4 and TSH levels were studied in six growth-retarded children with the Prader-Willi syndrome, of whom five had a 15 q - karyotype. Only one of the subjects was obese. All showed abnormally low growth hormone secretion. None achieved a nocturnal peak above 10 .mu.g/l, none had a mean noctural level over 1.8, and none showed a level above 8 .mu.g/l after clonidine provocation. These findings contrasted with normal TSH in all and normal T-4 in five. These findings suggest that the poor linear growth in the Prader-Willi syndrome is caused by a true deficiency of growth hormone secretion, and that the low growth hormone levels observed in such cases are not an artifact of obesity.Keywords
This publication has 7 references indexed in Scilit:
- Growth hormone testing in short children and their response to growth hormone therapyThe Journal of Pediatrics, 1989
- Growth hormone secretory profiles: Variation on consecutive nightsThe Journal of Pediatrics, 1989
- Variable Estimates of Serum Growth Hormone Concentrations by Different Radioassay SystemsJournal of Clinical Endocrinology & Metabolism, 1988
- Growth Hormone (GH) Provocative Testing Frequently Does Not Reflect Endogenous GH Secretion*Journal of Clinical Endocrinology & Metabolism, 1986
- Endocrinological Abnormalities in Prader-Willi SyndromePediatrics International, 1981
- Anterior Pituitary Function in the Prader-Labhart-Willi (PLW) SyndromeJournal of Clinical Endocrinology & Metabolism, 1974
- Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndromeThe Journal of Pediatrics, 1973